Drug Repurposing Study Shows PDE5 Inhibitors Do Not Reduce Dementia Risk

Phosphodiesterase 5 inhibitors (eg, sildenafil, tadalafil) do not appear to reduce the risk of Alzheimer disease and related dementias, according to an NIH study.

Related Keywords

,National Institutes Of Health ,Brain Communications ,National Institutes ,Drug Repurposing ,Effective Alzheimer Medicines ,Effective Alzheimer ,